ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,464.62
      -0.16%
      US Tech 100
      19,220.00
      -0.20%
      Dow Jones
      39,150.33
      0.04%
      Brent Oil
      84.39
      0.00%
      Bitcoin
      64,415.01
      0.26%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV
      6. Novo Nordisk (N1VO34)

      7. Novo Nordisk (N1VO34) Financials

      Novo Nordisk

      Novo Nordisk (N1VO34)

      BOV
      96.51
      0.09
      (0.09%)
      Closed June 22 4:55PM
      Delayed by 15 minutes

      Novo Nordisk Financial Summary

      The current N1VO34 market cap is 3.32T. The company's latest EPS is DKK 2.4362 and P/E is 56.96.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 53.37B54.3B58.73B65.86B65.35B
      Operating Income 25.01B23.89B26.91B26.85B31.85B
      Net Income 19.81B19.43B22.48B21.96B25.41B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 122.02B126.95B140.8B176.95B232.26B
      Operating Income 52.35B54.28B58.62B74.62B102.66B
      Net Income 38.95B42.14B47.76B55.53B83.68B

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 250.03B280.75B300.1B314.49B298.92B
      Total Liabilities 170.15B190.28B207.11B207.93B200.01B
      Total Equity 79.87B90.47B92.99B106.56B98.91B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 125.61B144.92B194.51B241.26B314.49B
      Total Liabilities 68.02B81.6B123.76B157.77B207.93B
      Total Equity 57.59B63.33B70.75B83.49B106.56B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 29.81B58.39B99.36B108.91B14.31B
      Investing -6.65B-15.93B-29.18B-43.89B3.96B
      Financing -20.62B-33.21B-53.04B-63.16B-26.38B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 46.78B51.95B55B78.89B108.91B
      Investing -11.51B-22.44B-31.61B-24.92B-43.89B
      Financing -35.48B-32.24B-25.49B-51.8B-63.16B

      Stats and Ratios

      Market Cap 3.32T
      Price to Earnings Ratio 56.96
      Price to Sales Ratio 20.52
      Price to Cash Ratio 331.17
      Price to Book Ratio 44.73
      Dividend Yield 0.67%

      Share Statistics

      Shares Outstanding 34.35B
      Average Volume (1 week) 6.93k
      Average Volume (1 Month) 7.91k
      52 Week Change 100.87%
      52 Week High 102.61
      52 Week Low 45.59
      Spread (Intraday) 4.49 (4.51%)

      Company Info

      Company Name Novo Nordisk
      Address novo alle
      bagsvaerd DK-2880
      Website https://www.novonordisk.com
      Industry pharmaceutical preparations (2834)